How I Do It: A Novel Case Series of Office-Based Laser Complete Excision of Vocal Fold Cysts.

LaryngoscopeMay 15, 2026 (epub)
Case ReportOtolaryngology (ENT)

Aurora Ka Yue Tam, Timothy Shun Man Chu, Yifeng Wei et al.

✦ AI-curated · Sources linked

Case in brief

The report describes office-based excision of vocal fold cysts using a Trublue laser delivered through transnasal flexible endoscopy. The cysts were removed en bloc under local anesthesia, and the procedure was reported as well tolerated. The authors present this approach as a technically feasible alternative to conventional marsupialization.

What made this case unusual

The reported approach enables complete, en bloc cyst removal in an office setting under local anesthesia, rather than conventional marsupialization.

Diagnostic / clinical pearl

Transnasal flexible endoscopy with a Trublue laser was reported as a technically feasible means of complete office-based vocal fold cyst excision under local anesthesia.

Source

PubMed · PMID 42141701

Published in Laryngoscope. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Otolaryngology (ENT)

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.